Recognition and treatment of panic disorder
- PMID: 18052552
- DOI: 10.4088/jcp.1107e26
Recognition and treatment of panic disorder
Abstract
Panic disorder is a common, disabling condition that affects 3% to 5% of the world's population. Although it is treatable, panic disorder goes unrecognized and untreated in many patients. Patients with panic disorder have an increased risk for other psychiatric disorders, especially other anxiety disorders, and panic disorder is associated with other medical conditions such as migraines, fibromyalgia, and irritable bowel syndrome. Clinicians treating panic disorder must be able to recognize the disorder, differentiate it from other disorders in which panic attacks are part of the symptomatology, and map out an individualized treatment plan for each patient. This presentation discusses the importance of collaboration between doctor and patient and details available treatment options, including antidepressants, benzodiazepines, and cognitive-behavioral therapy.
Similar articles
-
A meta-analysis of the treatment of panic disorder with or without agoraphobia: a comparison of psychopharmacological, cognitive-behavioral, and combination treatments.J Nerv Ment Dis. 1997 Aug;185(8):510-6. doi: 10.1097/00005053-199708000-00006. J Nerv Ment Dis. 1997. PMID: 9284865
-
WCA recommendations for the long-term treatment of panic disorder.CNS Spectr. 2003 Aug;8(8 Suppl 1):17-30. doi: 10.1017/s109285290000691x. CNS Spectr. 2003. PMID: 14767395 Review.
-
Predictors and time course of response among panic disorder patients treated with cognitive-behavioral therapy.J Clin Psychiatry. 2008 Mar;69(3):418-24. doi: 10.4088/jcp.v69n0312. J Clin Psychiatry. 2008. PMID: 18278989
-
Panic control treatment and its applications.J Psychother Pract Res. 1999 Winter;8(1):3-11. J Psychother Pract Res. 1999. PMID: 9888103 Free PMC article. Review.
-
Severity of panic disorder, adverse events in childhood, dissociation, self-stigma and comorbid personality disorders Part 2: Therapeutic effectiveness of a combined cognitive behavioural therapy and pharmacotherapy in treatment-resistant inpatients.Neuro Endocrinol Lett. 2019 Dec;40(6):271-283. Neuro Endocrinol Lett. 2019. PMID: 32200586
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical